Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.

Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, Hatakeyama J, Dorigo O, Barkal LJ, Weissman IL.

Nature. 2019 Aug;572(7769):392-396. doi: 10.1038/s41586-019-1456-0. Epub 2019 Jul 31.

PMID:
31367043
2.

Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.

Haney MS, Bohlen CJ, Morgens DW, Ousey JA, Barkal AA, Tsui CK, Ego BK, Levin R, Kamber RA, Collins H, Tucker A, Li A, Vorselen D, Labitigan L, Crane E, Boyle E, Jiang L, Chan J, Rincón E, Greenleaf WJ, Li B, Snyder MP, Weissman IL, Theriot JA, Collins SR, Barres BA, Bassik MC.

Nat Genet. 2018 Dec;50(12):1716-1727. doi: 10.1038/s41588-018-0254-1. Epub 2018 Nov 5.

3.

DNase-capture reveals differential transcription factor binding modalities.

Kang D, Sherwood R, Barkal A, Hashimoto T, Engstrom L, Gifford D.

PLoS One. 2017 Dec 28;12(12):e0187046. doi: 10.1371/journal.pone.0187046. eCollection 2017.

4.

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.

Barkal AA, Weiskopf K, Kao KS, Gordon SR, Rosental B, Yiu YY, George BM, Markovic M, Ring NG, Tsai JM, McKenna KM, Ho PY, Cheng RZ, Chen JY, Barkal LJ, Ring AM, Weissman IL, Maute RL.

Nat Immunol. 2018 Jan;19(1):76-84. doi: 10.1038/s41590-017-0004-z. Epub 2017 Nov 27.

5.

An atlas of transcriptional, chromatin accessibility, and surface marker changes in human mesoderm development.

Koh PW, Sinha R, Barkal AA, Morganti RM, Chen A, Weissman IL, Ang LT, Kundaje A, Loh KM.

Sci Data. 2016 Dec 20;3:160109. doi: 10.1038/sdata.2016.109.

6.

Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20.

Weiskopf K, Anderson KL, Ito D, Schnorr PJ, Tomiyasu H, Ring AM, Bloink K, Efe J, Rue S, Lowery D, Barkal A, Prohaska S, McKenna KM, Cornax I, O'Brien TD, O'Sullivan MG, Weissman IL, Modiano JF.

Cancer Immunol Res. 2016 Dec;4(12):1072-1087. Epub 2016 Nov 14.

7.

A synergistic DNA logic predicts genome-wide chromatin accessibility.

Hashimoto T, Sherwood RI, Kang DD, Rajagopal N, Barkal AA, Zeng H, Emons BJ, Srinivasan S, Jaakkola T, Gifford DK.

Genome Res. 2016 Oct;26(10):1430-1440. Epub 2016 Jul 25.

8.

Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types.

Loh KM, Chen A, Koh PW, Deng TZ, Sinha R, Tsai JM, Barkal AA, Shen KY, Jain R, Morganti RM, Shyh-Chang N, Fernhoff NB, George BM, Wernig G, Salomon REA, Chen Z, Vogel H, Epstein JA, Kundaje A, Talbot WS, Beachy PA, Ang LT, Weissman IL.

Cell. 2016 Jul 14;166(2):451-467. doi: 10.1016/j.cell.2016.06.011.

9.

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.

Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, Guerston H, Barkal A, Trapani F, George J, Poirier JT, Gardner EE, Miles LA, de Stanchina E, Lofgren SM, Vogel H, Winslow MM, Dive C, Thomas RK, Rudin CM, van de Rijn M, Majeti R, Garcia KC, Weissman IL, Sage J.

J Clin Invest. 2016 Jul 1;126(7):2610-20. doi: 10.1172/JCI81603. Epub 2016 Jun 13.

10.

Cas9 Functionally Opens Chromatin.

Barkal AA, Srinivasan S, Hashimoto T, Gifford DK, Sherwood RI.

PLoS One. 2016 Mar 31;11(3):e0152683. doi: 10.1371/journal.pone.0152683. eCollection 2016.

11.

Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape.

Sherwood RI, Hashimoto T, O'Donnell CW, Lewis S, Barkal AA, van Hoff JP, Karun V, Jaakkola T, Gifford DK.

Nat Biotechnol. 2014 Feb;32(2):171-178. doi: 10.1038/nbt.2798. Epub 2014 Jan 19.

12.

Influence of sialic acid groups on the retention of glycosphingolipids in blood plasma.

Barkal A, Di Cesare JL.

Biochim Biophys Acta. 1975 Aug 25;398(2):287-93.

PMID:
1182139

Supplemental Content

Loading ...
Support Center